January 30, 2015 3:30 PM ET

Healthcare Equipment and Supplies

Company Overview of SpineVision, Inc.

Company Overview

SpineVision, Inc., a spinal technology company, engages in designing, developing, and marketing implants and instrumentation for spinal surgeries. It offers perforation instrument to detect iatrogenic breach in the vertebral pedicle; devices for anterior cervical interbody fusion; pivot link systems; anterior cervical plate systems for anterior cervical constructs; and thorac-lumbar spinal systems. The company also involves in developing products in the area of motion preservation and minimal invasive surgery. Its products offer solutions for various spinal pathologies, such as deformities, lumbar degenerative disc diseases, cervical disorders, trauma, and tumors. The company is based in Sau...

1505 Bridgeway

Suite 118

Sausalito, CA 94965-1967

United States

Phone:

415-494-8150

Fax:

888-770-4119

Key Executives for SpineVision, Inc.

Chief Financial Officer
Director of Operations
Managing Director of UK Operations
Vice President of Regulatory Affairs and Quality Assurance
Director of France-Belux Operations
Compensation as of Fiscal Year 2014.

SpineVision, Inc. Key Developments

SpineVision, Inc. Expands Flex+2(TM) Product Family

SpineVision, Inc. announced that it has: expanded its Flex+2(TM) dynamic stabilization platform offerings with the addition of the prebent Flex+(TM)2 for use in hybrid cases; and, received regulatory approval to market its Flex+2(TM) products in Brazil. Earlier in 2013, SpineVision(R) started selling its new-generation Flex+2(TM) dynamic and hybrid stabilization rod in Europe. In addition, 510(k) approval has been granted in the United States for a range of surgical instrumentation focused on a minimally invasive approach to treating conditions related to aging and degeneration of the spine.

Dsm Polymer Technology Group, Inc. Signs New License to Supply Bionate(R) Ii PCU for Use in SpineVision's

DSM, a announced that the company has signed a license and supply agreement with spinal implant and surgical systems developer, SpineVision(R). The agreement grants SpineVision(R) the use of Bionate(R) II PCU, a proprietary DSM polymer, in its new Flex(+/-) 2(TM) system. The system is adaptable to the various stages of disc degeneration from early degeneration of intervertebral discs to total disc degeneration requiring fusion procedures. This level of flexibility not only offers spine surgeons more options in the treatment of lumbar disc diseases, but also allows selective segmental stabilization to better treat disc degeneration throughout multiple stages. The Flex(+) 2(TM) system utilizes a top-loading, top-tightening design, which accommodates both open and percutaneous approaches. DSM's Bionate(R) II PCU encapsulates the metal wire and provides the system with enhanced frontal and sagittal stabilization, assuring flexion and extension, which allow for increased freedom of movement and better accommodation to the spine without loss of strength or stability.

Similar Private Companies By Industry

Company Name Region
ICS of North America Inc United States
EndoEvolution, LLC United States
Upex, LLC United States
Faxitron Bioptics, LLC United States
Sanarus Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SpineVision, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.